PlainRecalls
FDA Devices Moderate Class II Ongoing

DxI 9000 Access Immunoassay Analyzer, REF C11137, Sofware Versions 1.15 and below; invitro diagnostic

Reported: October 18, 2023 Initiated: September 12, 2023 #Z-0107-2024

Product Description

DxI 9000 Access Immunoassay Analyzer, REF C11137, Sofware Versions 1.15 and below; invitro diagnostic

Reason for Recall

The firm has investigated and confirmed that when DxI 9000 is connected to Laboratory Information System (LIS, host), the sample barcode presented may be ignored and replaced with a sample ID that was previously in the same rack and position. This will cause a delay of result to the sample currently presented to the system (Sample B) and may result in an erroneous test result for the prior sample (Sample A), which gets associated with the results of sample B.

Details

Recalling Firm
Beckman Coulter, Inc.
Units Affected
36 units
Distribution
Worldwide - US Nationwide distribution in the state of Florida, and the countries of Croatia, Czechia, France, Germany, Ireland, Italy, Netherlands, New Zealand, South Africa, Spain, Switzerland, United Kingdom of Great Britain and Northern Ireland.
Location
Chaska, MN

Frequently Asked Questions

What product was recalled?
DxI 9000 Access Immunoassay Analyzer, REF C11137, Sofware Versions 1.15 and below; invitro diagnostic. Recalled by Beckman Coulter, Inc.. Units affected: 36 units.
Why was this product recalled?
The firm has investigated and confirmed that when DxI 9000 is connected to Laboratory Information System (LIS, host), the sample barcode presented may be ignored and replaced with a sample ID that was previously in the same rack and position. This will cause a delay of result to the sample currently presented to the system (Sample B) and may result in an erroneous test result for the prior sample (Sample A), which gets associated with the results of sample B.
Which agency issued this recall?
This recall was issued by the FDA Devices on October 18, 2023. Severity: Moderate. Recall number: Z-0107-2024.